FDA Device Intelligence
Home › HARDY DIAGNOSTICS › NA

NA

HARDY DIAGNOSTICS · Model X52 · UDI-DI 00816576021116

JTY Prescription
10
510(k) clearances
82
Adverse events
9
Recalls
6
Facilities

Description

TRANSGROW (Modified Martin Lewis Agar with Lincomycin with CO2) For isolation of Neisseria gonorrhoeae. Hold bottle upright when cap is off. Do not refrigerate after inoculation.

Recalls

DateFirmReason
2026-06-03Remel, IncReduced or no recovery of some strains of Neisseria gonorrhoeae.
2022-11-21Becton Dickinson & Co.Boxes contain a reduced concentration of Nicotinamide Adenine Dinucleotide and does not provide enough of the blood factors necessary to support Haemophilus growth. The reduction c
2021-03-17Becton Dickinson & Co.Products show heavy growth of C. albicans after 24 hours of incubation due to misformulation (expected reaction is partial inhibition after 18-48 hours incubation) and reduce the
2021-03-17Becton Dickinson & Co.Products show heavy growth of C. albicans after 24 hours of incubation due to misformulation (expected reaction is partial inhibition after 18-48 hours incubation) and reduce the
2018-06-21Becton Dickinson & Co.A portion of this lot was manufactured using Gentamicin instead of Vancomycin. Gentamicin is an inhibitory agent of Neisseria organisms. This product is a selective plated medium t
2013-02-08Becton Dickinson & Co.Increased levels of false positives in BD Probe Tech Neisseria gonorrhoeae Q Amplified DNA assay kits.
2003-10-10Becton Dickinson & CoMicrobiological media may exhibit reduced colony size of bacteria, Haemophilus species.
2003-10-02Remel, IncSome of the product lots exhibit no growth of quality control strains of Neisseria gonorrhoeae
2002-11-18Becton Dickinson & Co.Microbiological media may exhibit No Growth or reduced colony size of Haemophilus species.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.